GSIE - ETF AI Analysis

Top Page

Goldman Sachs ActiveBeta International Equity ETF (GSIE)

Rating:65Neutral

Price Target:―

The Goldman Sachs ActiveBeta International Equity ETF (GSIE) has a solid overall rating, driven by strong contributions from holdings like Novartis AG and HSBC. Novartis stands out for its robust profitability, stable balance sheet, and growth in key products, while HSBC benefits from strong financial performance and positive corporate events. However, weaker technical momentum in holdings like SAP SE and Allianz may have slightly held back the fund’s rating. A key risk factor is the ETF's exposure to diverse regions, which could introduce volatility depending on global market conditions.

Positive Factors

Strong Top Holdings

Several of the ETF's largest positions, such as ASML Holding NV and Banco Santander, have delivered strong year-to-date performance, supporting overall returns.

Global Diversification

The ETF is geographically diversified across major economies like Japan, the UK, and Germany, reducing reliance on any single country.

Low Expense Ratio

With an expense ratio of 0.25%, this ETF is cost-efficient compared to many actively managed funds.

Negative Factors

Underperforming Holdings

Some top holdings, such as SAP SE, have lagged in performance, which could weigh on the ETF's future returns.

Sector Concentration in Financials

The ETF has significant exposure to the financial sector, which could make it vulnerable to sector-specific downturns.

Mixed Short-Term Performance

The ETF's one-month performance has been slightly negative, indicating potential short-term volatility.

GSIE Historical Chart

AUM5.15B

RegionDeveloped Markets

Expense Ratio0.25%

Beta0.67

IssuerGoldman Sachs

Inception DateNov 06, 2015

Dividend Yield2.68%

Asset ClassEquity

Index TrackedStuttgart Goldman Sachs ActiveBeta Intl.Equity (USD)

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume753,028

30 Day Avg. Volume435,108

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

47.11

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering637

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

GSIE Summary

The Goldman Sachs ActiveBeta International Equity ETF (GSIE) is an investment fund that focuses on stocks from countries outside the U.S., such as Japan, the UK, and Germany. It uses a strategy to pick companies based on factors like value, quality, and stability. Some well-known companies it includes are Nestlé and ASML Holding. This ETF is a good option for investors looking to diversify their portfolios with international stocks and benefit from potential growth in global markets. However, new investors should know that its performance can be affected by changes in international economies and currency fluctuations.

How much will it cost me?The expense ratio for the Goldman Sachs ActiveBeta International Equity ETF (GSIE) is 0.25%, which means you’ll pay $2.50 per year for every $1,000 invested. This is lower than average for actively managed ETFs because it uses a factor-based strategy rather than traditional stock-picking, keeping costs relatively modest.

What would affect this ETF?The GSIE ETF, with its focus on developed markets outside the U.S., could benefit from economic growth in Europe and Asia, particularly if industries like financials and technology, which have significant weight in the fund, experience expansion. However, it may face challenges from rising interest rates or geopolitical tensions that could negatively impact international markets and sectors like financials and consumer cyclical. Additionally, regulatory changes in key regions or currency fluctuations could influence the ETF's performance.

GSIE Top 10 Holdings

The Goldman Sachs ActiveBeta International Equity ETF (GSIE) leans heavily on financials, with names like HSBC and Banco Santander rising steadily and driving performance thanks to strong earnings and strategic initiatives. Health care stocks, including Roche and Novartis, add stability with robust pipelines and growth potential, while AstraZeneca shows mixed momentum. Technology exposure is lighter, with SAP lagging due to bearish trends. Overall, the fund’s developed markets focus provides a global mix, but its concentration in financials and health care suggests a tilt toward defensive and steady-growth sectors.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ASML	ASML Holding NV	1.61%	$83.22M	€414.15B	52.06%	76 Outperform
ROG	Roche Holding AG	1.12%	$57.76M	CHF275.00B	44.94%	73 Outperform
NOVN	Novartis AG	1.07%	$55.42M	CHF220.89B	28.13%	80 Outperform
HSBA	HSBC Holdings	0.99%	$51.27M	£208.34B	50.80%	80 Outperform
RY	Royal Bank Of Canada	0.96%	$49.85M	$235.97B	40.76%	75 Outperform
AZN	AstraZeneca	0.91%	$47.20M	£222.43B	34.73%	80 Outperform
SAN	Banco Santander	0.85%	$43.75M	€153.93B	127.26%	73 Outperform
SAP	SAP SE	0.80%	$41.43M	€234.66B	-17.30%	66 Neutral
6857	Advantest	0.71%	$36.86M	¥16.87T	144.96%	75 Outperform
NESN	Nestlé SA	0.67%	$34.75M	CHF193.47B	17.08%	71 Outperform

GSIE Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

42.15

Positive

100DMA

41.49

Positive

200DMA

39.63

Positive

Market Momentum

MACD

0.54

Negative

RSI

68.26

Neutral

STOCH

87.46

Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GSIE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 43.27, equal to the 50-day MA of 42.15, and equal to the 200-day MA of 39.63, indicating a bullish trend. The MACD of 0.54 indicates Negative momentum. The RSI at 68.26 is Neutral, neither overbought nor oversold. The STOCH value of 87.46 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GSIE.

GSIE Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
GSIE	―	―	$5.15B	0.25%	―
LVHI	―	―	$3.87B	0.40%	―
IMTM	―	―	$3.67B	0.30%	―
INTF	―	―	$3.03B	0.16%	―
IDMO	―	―	$2.62B	0.25%	―
PXF	―	―	$2.35B	0.43%	―

Performance Comparison

GSIE

Goldman Sachs ActiveBeta International Equity ETF

44.06

11.41

34.95%

LVHI

Legg Mason International Low Volatility High Dividend ETF

―

IMTM

iShares MSCI Intl Momentum Factor ETF

―

INTF

iShares MSCI Intl Multifactor ETF

―

IDMO

Invesco S&P International Developed Momentum ETF

―

PXF

Invesco FTSE RAFI Developed Markets ex-U.S. ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents